Literature DB >> 27255463

Partnered pharmacist charting on admission in the General Medical and Emergency Short-stay Unit - a cluster-randomised controlled trial in patients with complex medication regimens.

E Y Tong1, C Roman1, B Mitra2, G Yip3, H Gibbs3, H Newnham3, D P Smit2, K Galbraith4, M J Dooley1,4.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Patients admitted to general medical units and emergency short-stay units are often complex with multiple comorbidities, polypharmacy and at risk for drug-related problems associated with increased morbidity and mortality. The aim of this study was to evaluate the effectiveness of a partnered pharmacist charting model completed at the time of admission to prevent medication errors.
METHODS: We conducted an unblinded cluster randomized controlled trial comparing partnered pharmacist charting to standard medical charting among patients admitted to general medical units and emergency short-stay units with complex medication regimens or polypharmacy. This trial was conducted at an adult major referral hospital in metropolitan Melbourne, Australia, with an annual emergency department attendance of approximately 60 000 patients. The evaluation included patients' medication charts written in the period of 16 March 2015 to 27 July 2015. Patients randomized to the intervention were managed using the partnered pharmacist charting model. The primary outcome variable was a medication error identified by an independent assessor within 24 h of admission, who was not part of the patient's admission process.
RESULTS: Of the 473 patients who received standard medical staff charting during the study period, 372 (78·7%) had at least one medication error identified compared to 15 patients (3·7%) on the partnered pharmacist charting arm (P < 0·001). The relative risk of an error with standard medical charting was 21·4 (95% CI: 13·0-35·0) with a number needed to treat (NNT) to prevent one error of 1·3 (95% CI: 1·3-1·4), and the relative risk of a high or extreme risk error with standard medical charting was 150·9 (95% CI: 21·2-1072·9) with a NNT to prevent one high or extreme error of 2·7 (95% CI 2·4-3·1). WHAT IS NEW AND
CONCLUSION: Partnering between medical staff and pharmacists to jointly chart initial medications on admission significantly reduced inpatient medication errors (including errors of high and extreme risk) among general medical and emergency short-stay patients with complex medication regimens or polypharmacy.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  accident and emergency departments; medication; pharmacists; prescribing; prescribing practices

Mesh:

Year:  2016        PMID: 27255463     DOI: 10.1111/jcpt.12405

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  10 in total

1.  Multi-site evaluation of partnered pharmacist medication charting and in-hospital length of stay.

Authors:  Erica Y Tong; Biswadev Mitra; Gary Yip; Kirstie Galbraith; Michael J Dooley
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

Review 2.  Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review.

Authors:  Lorenz Van der Linden; Julie Hias; Karolien Walgraeve; Johan Flamaing; Jos Tournoy; Isabel Spriet
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

3.  Development of Screening Tools to Predict Medication-Related Problems Across the Continuum of Emergency Department Care: A Prospective, Multicenter Study.

Authors:  Simone E Taylor; Elise A Mitri; Andrew M Harding; David McD Taylor; Adrian Weeks; Leonie Abbott; Pani Lambros; Dona Lawrence; Dana Strumpman; Reyhan Senturk-Raif; Stephen Louey; Hamish Crisp; Emily Tomlinson; Elizabeth Manias
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

Review 4.  Reducing medication errors for adults in hospital settings.

Authors:  Agustín Ciapponi; Simon E Fernandez Nievas; Mariana Seijo; María Belén Rodríguez; Valeria Vietto; Herney A García-Perdomo; Sacha Virgilio; Ana V Fajreldines; Josep Tost; Christopher J Rose; Ezequiel Garcia-Elorrio
Journal:  Cochrane Database Syst Rev       Date:  2021-11-25

5.  Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.

Authors:  Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee
Journal:  Ment Health Clin       Date:  2020-11-05

6.  Pharmacist-assisted electronic prescribing at the time of admission to an inpatient orthopaedic unit and its impact on medication errors: a pre- and postintervention study.

Authors:  Tim Tran; Simone E Taylor; Andrew Hardidge; Elise Mitri; Parnaz Aminian; Johnson George; Rohan A Elliott
Journal:  Ther Adv Drug Saf       Date:  2019-07-12

7.  A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.

Authors:  Rabia Hussain; Mohamed Azmi Hassali; Anees Ur Rehman; Jaya Muneswarao; Muhammad Atif; Zaheer-Ud-Din Babar
Journal:  Int J Environ Res Public Health       Date:  2020-04-27       Impact factor: 3.390

8.  Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals.

Authors:  Courtney Ierano; Karin Thursky; Trisha Peel; Arjun Rajkhowa; Caroline Marshall; Darshini Ayton
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

9.  Hospital pharmacists' experiences of participating in a partnered pharmacist medication charting credentialing program: a qualitative study.

Authors:  Hannah Beks; Kevin Mc Namara; Elizabeth Manias; Andrew Dalton; Erica Tong; Michael Dooley
Journal:  BMC Health Serv Res       Date:  2021-03-19       Impact factor: 2.655

10.  Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.

Authors:  Michael Bakker; Michaela E Johnson; Lauren Corre; Deanna N Mill; Xingzhuo Li; Richard J Woodman; Jacinta L Johnson
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.